Table 1.

General clinical and demographic characteristics of the study population (n: 121)

Variables	Values
Age, years	58.49±8.04
Male, n, %	51 (42.1%)
BMI, kg/m2	32.26±4.89
Hypertension-duration, years	7 (range: 0.5-20), [5-10]
Diabetes mellitus-duration, years	6 (range: 0.5-12), [3-9]
Smokers, %	14 (11.6%)
ACE inhibitors, ARB %	103 (85.1%)
Beta-blockers %	48 (39.7%)
Calcium channel blockers %	38 (31.4%)
MDRD eGFR, mL/min	86.97±18.27
Fasting plasma glucose, mg/dL	134 (range: 63-392), [115.5-172.5]
Triglycerides, mg/dL	190.51±163.44
Total cholesterol, mg/dL	193.84±42.29
LDL cholesterol, mg/dL	127 (range: 65-251), [107.5-145]
HDL cholesterol, mg/dL	44.78±9.24
HbA1c, %	8.04±1.57
Overall systolic BP, mm Hg	139.98±15.59
Overall diastolic BP, mm Hg	78.28±9.28
Overall pulse pressure, mm Hg	61.69±11.04
Overall heart rate	70.69±8.64
Office systolic BP, mm Hg	149.31±12.09
Office diastolic BP, mm Hg	89.44±9.64
Office pulse pressure, mm Hg	59.88±8.88
Office heart rate	73.17±12.91
Carotid intima-media thickness, mm	0.7 (range: 0.4-1.5), [0.6-0.9]
AASI	0.51±0.13

Data are expressed in numbers (percentages), mean±1 SD or median and [range, (25% percentile-75% percentile)]. Percentages are rounded.

AASI - ambulatory artery stiffness index; ACE - angiotensin-converting enzyme;

ARB - angiotensin receptor blocker; BMI - body mass index; BP - blood pressure; eGFR - estimated glomerular filtration fraction; HDL - high-density lipoprotein; LDL - low-density lipoprotein; MDRD - modification of diet in renal disease